Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;77(7):710-730.
doi: 10.1038/s41430-022-01232-0. Epub 2022 Nov 9.

Micronutrient supplementation interventions in preconception and pregnant women at increased risk of developing pre-eclampsia: a systematic review and meta-analysis

Sowmiya Gunabalasingam  1 , Daniele De Almeida Lima Slizys  1 , Ola Quotah  1 , Laura Magee  1 , Sara L White  1 , Jessica Rigutto-Farebrother  2 , Lucilla Poston  1 , Kathryn V Dalrymple #  3 , Angela C Flynn #  4
Affiliations
Review

Micronutrient supplementation interventions in preconception and pregnant women at increased risk of developing pre-eclampsia: a systematic review and meta-analysis

Sowmiya Gunabalasingam et al. Eur J Clin Nutr. 2023 Jul.

Abstract

Background: Pre-eclampsia can lead to maternal and neonatal complications and is a common cause of maternal mortality worldwide. This review has examined the effect of micronutrient supplementation interventions in women identified as having a greater risk of developing pre-eclampsia.

Methods: A systematic review was performed using the PRISMA guidelines. The electronic databases MEDLINE, EMBASE and the Cochrane Central Register of Controlled trials were searched for relevant literature and eligible studies identified according to a pre-specified criteria. A meta-analysis of randomised controlled trials (RCTs) was conducted to examine the effect of micronutrient supplementation on pre-eclampsia in high-risk women.

Results: Twenty RCTs were identified and supplementation included vitamin C and E (n = 7), calcium (n = 5), vitamin D (n = 3), folic acid (n = 2), magnesium (n = 1) and multiple micronutrients (n = 2). Sample size and recruitment time point varied across studies and a variety of predictive factors were used to identify participants, with a previous history of pre-eclampsia being the most common. No studies utilised a validated prediction model. There was a reduction in pre-eclampsia with calcium (risk difference, -0.15 (-0.27, -0.03, I2 = 83.4%)), and vitamin D (risk difference, -0.09 (-0.17, -0.02, I2 = 0.0%)) supplementation.

Conclusion: Our findings show a lower rate of pre-eclampsia with calcium and vitamin D, however, conclusions were limited by small sample sizes, methodological variability and heterogeneity between studies. Further higher quality, large-scale RCTs of calcium and vitamin D are warranted. Exploration of interventions at different time points before and during pregnancy as well as those which utilise prediction modelling methodology, would provide greater insight into the efficacy of micronutrient supplementation intervention in the prevention of pre-eclampsia in high-risk women.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. PRISMA Flow Diagram.
Flow diagram showing the study selection process.
Fig. 2
Fig. 2. Forest plot of risk difference (95% CI) for overall pre-eclampsia, stratified by supplementation.
Forest plot assessing risk of overall pre-eclampsia with calcium, folic acid, vitamin C and E, vitamin D or multi-micronutrient supplementation. Key: (1) includes linoleic acid (2) includes calcium (3) includes L-arginine (4) all participants given ferrous sulfate tablets.
Fig. 3
Fig. 3. Forest plot of risk difference (95% CI) for severe pre-eclampsia only, stratified by supplementation.
Forest plot assessing risk of severe pre-eclampsia with calcium, folic acid or vitamin C and E supplementation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization. WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia [Internet]. 2011 [cited 2021 Sep 2]. Available from: http://apps.who.int/iris/bitstream/handle/10665/44703/9789241548335_eng.pdf - PubMed
    1. NICE. Hypertension in pregnancy: diagnosis and management NICE guideline [Internet]. 2019. Available from: www.nice.org.uk/guidance/ng133
    1. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999–1011. doi: 10.1016/S0140-6736(15)00070-7. - DOI - PubMed
    1. Rawlins B, Plotkin M, Rakotovao JP, Getachew A, Vaz M, Ricca J, et al. Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: Findings from cross-sectional observation studies in six sub-Saharan African countries. BMC Pregnancy Childbirth. 2018;18:1–11. doi: 10.1186/s12884-018-1972-1. - DOI - PMC - PubMed
    1. Burton GJ, Redman CW, Roberts JM, Moffett A Pre-eclampsia: pathophysiology and clinical implications. Vol. 366, The BMJ. BMJ Publishing Group; 2019. - PubMed